Yuko Akiyama

1.3k citations

28 papers · 1.0k indexed · 1 hit paper · h-index 15

Co-authors: Yasutsuna Sasaki Ken‐ichi Fujita Manuela Raffatellu Michael D. George Renato L. Santos Hiutung Chu Brian P. Butler Charles Bevins
Topics: Cancer therapeutics and mechanisms (7 papers)Drug Transport and Resistance Mechanisms (5 papers)Colorectal Cancer Treatments and Studies (5 papers)
Cited by: Endocrinology Pharmacology Oncology
Journals: Biochemical and Biophysical Research Communications Journal of Pharmacology and Experimental Therapeutics Cell Host & Microbe
Partner nations: Japan Canada United States

In The Last Decade

Yuko Akiyama

28 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipocalin-2 Resistance Confers an Advantage to Salmonella enterica Serotype Typhimurium for Growth and Survival in the Inflamed Intestine

2009 419 citations Manuela Raffatellu, Michael D. George et al. Cell Host & Microbe profile →

Peers

Countries citing papers authored by Yuko Akiyama

Since Specialization

Citations

This map shows the geographic impact of Yuko Akiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Akiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Akiyama more than expected).

Fields of papers citing papers by Yuko Akiyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Akiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Akiyama. The network helps show where Yuko Akiyama may publish in the future.

Co-authorship network of co-authors of Yuko Akiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Akiyama. A scholar is included among the top collaborators of Yuko Akiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Akiyama. Yuko Akiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Subcutaneous abscess in the shoulder caused by Prevotella bivia infection 2022 ·Anaerobe ·(unknown),Megumi Hirabayashi,(unknown),Yuko Akiyama,(unknown),(unknown),(unknown),(unknown),Yoshihiro Kuwano	2
2	Prophylactic antimicrobials may not be needed to prevent surgical site infection after skin biopsy: a retrospective study 2022 ·Antimicrobial Resistance and Infection Control ·Yuko Akiyama,Yuta Norimatsu,Yuki Ohno	2
3	Osteogenic Gene Transcription Is Regulated via Gap Junction-Mediated Cell–Cell Communication 2014 ·Stem Cells and Development ·Yoshikazu Mikami,Kiyofumi Yamamoto,Yuko Akiyama,Masayuki Kobayashi,(unknown),Nobukazu Watanabe,Masatake Asano,Noriyoshi Shimizu,Kazuo Komiyama	11
4	Periodontal tissue regeneration by transplantation of rat adipose-derivedstromal cells in combination with PLGA-based solid scaffolds 2014 ·Biomedical Research ·Daisuke Akita,(unknown),Yōko Saitō,Katsuyuki Yamanaka,Yuko Akiyama,Momoko Sato,(unknown),Taku Toriumi,Yoshinori Arai,Tadashi Kaneko,Naoki Tsukimura,Keitaro Isokawa,Tomohiko Ishigami,(unknown)	38
5	Osteocytes up-regulate the terminal differentiation of pre-osteoblasts via gap junctions 2014 ·Biochemical and Biophysical Research Communications ·(unknown),Yuko Akiyama,Kiyofumi Yamamoto,Masayuki Kobayashi,(unknown),Nobukazu Watanabe,Noriyoshi Shimizu,Yoshikazu Mikami,Kazuo Komiyama	10
6	The P75 neurotrophin receptor regulates proliferation of the human MG63 osteoblast cell line 2014 ·Differentiation ·Yuko Akiyama,Yoshikazu Mikami,(unknown),Nobukazu Watanabe,Taku Toriumi,Tomihisa Takahashi,Kazuo Komiyama,Keitaro Isokawa,Noriyoshi Shimizu,Masaki Honda	14
7	Pharmacological Evaluation of Adipose Dysfunction via 11β-Hydroxysteroid Dehydrogenase Type 1 in the Development of Diabetes in Diet-Induced Obese Mice with Cortisone Pellet Implantation 2014 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Yuko Akiyama,Hideaki Kato,Takayuki Kuroda,Takashi Ono,Keiichi Imagawa,Kenji Asakura,Toshihiro Shinosaki,Toshihiko Murayama,Kohji Hanasaki	4
8	A Phase I Study of Infusional 5-Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan in Japanese Patients with Advanced Colorectal Cancer Who Harbor <i>UGT1A1</i><i>1/</i><i>1</i>,<i>1/</i><i>6</i> or <i>1/</i><i>28</i> 2012 ·Oncology ·Yu Sunakawa,Ken‐ichi Fujita,Wataru Ichikawa,Hiroo Ishida,Keishi Yamashita,Kazuhiro Araki,Keisuke Miwa,Kaori Kawara,Yuko Akiyama,Wataru Yamamoto,Fumio Nagashima,Shigehira Saji,Yasutsuna Sasaki	17
9	N-Isopropyl-p-iodoamphetamine Hydrochloride Is Predominantly Metabolized by CYP2C19 2012 ·Drug Metabolism and Disposition ·Ken‐ichi Fujita,Minako Sugiyama,Yuko Akiyama,Kazuhito Hioki,Munetaka Kunishima,Kodai Nishi,Masato Kobayashi,Keiichi Kawai,Yasutsuna Sasaki	2
10	Association of ABCC2 Genotype with Efficacy of First-line FOLFIRI in Japanese Patients with Advanced Colorectal Cancer 2011 ·Drug Metabolism and Pharmacokinetics ·Yuko Akiyama,Ken‐ichi Fujita,Hiroo Ishida,Yu Sunakawa,Keishi Yamashita,Kaori Kawara,Keisuke Miwa,Shigehira Saji,Yasutsuna Sasaki	26
11	Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation 2011 ·Drug Metabolism and Disposition ·Minako Sugiyama,Ken‐ichi Fujita,Norie Murayama,Yuko Akiyama,Hiroshi Yamazaki,Yasutsuna Sasaki	43
12	SIMULTANEOUS BILATERAL CENTRAL RETINAL ARTERY OCCLUSION IN CHURG–STRAUSS SYNDROME 2011 ·Retinal Cases & Brief Reports ·Yuko Akiyama,Kei Shinoda,(unknown),(unknown),Atsushi Mizota	2
13	UGT1A11/28 and 1/6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer 2010 ·Cancer Chemotherapy and Pharmacology ·Yu Sunakawa,Wataru Ichikawa,Ken‐ichi Fujita,Fumio Nagashima,Hiroo Ishida,Keishi Yamashita,Keiko Mizuno,Keisuke Miwa,Kaori Kawara,Yuko Akiyama,Kazuhiro Araki,Wataru Yamamoto,Toshimichi Miya,Masaru Narabayashi,Yukio Ando,Takashi Hirose,Shigehira Saji,Yasutsuna Sasaki	33
14	Phase I/II Study of FOLFIRI in Japanese Patients with Advanced Colorectal Cancer 2010 ·Japanese Journal of Clinical Oncology ·Koji Yamashita,Fumio Nagashima,K Fujita,Wataru Yamamoto,H. Endo,(unknown),Masaru Narabayashi,Kaori Kawara,Yuko Akiyama,Yukio Ando,Masahiko Ando,Yosuke Sasaki	8
15	Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells 2010 ·European Journal of Pharmacology ·Tatsuo Kobayashi,Yuko Akiyama,(unknown),(unknown),Sachiko Yamamoto,(unknown),Toru Yanagimoto,Mitsuru Notoya,Kenji Asakura,Toshihiro Shinosaki,Kohji Hanasaki	7
16	Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer 2009 ·Cancer Chemotherapy and Pharmacology ·Ken‐ichi Fujita,Yukio Ando,Wataru Yamamoto,Toshimichi Miya,Hisashi Endo,Yu Sunakawa,Kazuhiro Araki,Keiji Kodama,Fumio Nagashima,Wataru Ichikawa,Masaru Narabayashi,Yuko Akiyama,Kaori Kawara,(unknown),Hiroyasu Ogata,Hiroyasu Iwasa,Yasushi Okazaki,Takashi Hirose,Yasutsuna Sasaki	82
17	Lipocalin-2 Resistance Confers an Advantage to Salmonella enterica Serotype Typhimurium for Growth and Survival in the Inflamed Intestinebreakdown → 2009 ·Cell Host & Microbe ·Manuela Raffatellu,Michael D. George,Yuko Akiyama,Michael Hornsby,Sean‐Paul Nuccio,Tatiane A. Paíxão,Brian P. Butler,Hiutung Chu,Renato L. Santos,Thorsten Berger,Tak W. Mak,Renée M. Tsolis,Charles Bevins,Jay V. Solnick,Satya Dandekar,Andreas J. Bäumler	419
18	CYP2A6and the plasma level of 5‐chloro‐2, 4‐dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5‐fluorouracil, respectively, in Japanese patients with cancer given S‐1 2008 ·Cancer Science ·Ken‐ichi Fujita,Wataru Yamamoto,(unknown),Hisashi Endo,Fumio Nagashima,Wataru Ichikawa,Ryuhei Tanaka,Toshimichi Miya,Kazuhiro Araki,Keiji Kodama,Yu Sunakawa,Masaru Narabayashi,Keisuke Miwa,Yukio Ando,Yuko Akiyama,Kaori Kawara,Tetsuya Kamataki,Yasutsuna Sasaki	46
19	Removal of hazardous phenols by microalgae under photoautotrophic conditions 2003 ·Journal of Bioscience and Bioengineering ·Takashi Hirooka,Yuko Akiyama,Naoki Tsuji,Takanori Nakamura,Hiroyasu Nagase,Kazumasa Hirata,Kazuhisa Miyamoto	92
20	Malignant Fibrous Histiocytoma in the Hypopharynx; A Case Report. 1995 ·Practica Oto-Rhino-Laryngologica ·Masataka Murakami,Yuko Akiyama,(unknown),Takashi Shinomiya	1

About Yuko Akiyama

Yuko Akiyama is a scholar working on Pharmacology, Oncology and Genetics, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Endocrinology (84 citations), Pharmacology (98 citations) and Oncology (252 citations). Yuko Akiyama has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Yasutsuna Sasaki, Ken‐ichi Fujita, Manuela Raffatellu, Michael D. George, Renato L. Santos, Hiutung Chu, Brian P. Butler, Charles Bevins, Sean‐Paul Nuccio and Andreas J. Bäumler. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Cell Host & Microbe.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact